Work With Data
search
Profile
user
live In the news:
Wegovy sales took a hit this year. Novo's CEO blames off-brand competition / Shortage of Novo's Wegovy and Ozempic is resolved, FDA website shows / Novo Blames US Health System After Sanders' Wegovy Criticism / Novo to use Ozempic and Wegovy windfall to invest $7bn a year by 2030

Novo Cursoadsumus

Updated: 43d ago

Novo Cursoadsumus is a company. It is a private company in Brazil.

Key facts

  • country: Brazil
  • employees: 1,295 people
  • revenues: 29.8M $
  • company type: private
  • ESG score: 79.54 / 100
plus See more facts
link Website

Extract data

Download datasets about Novo Cursoadsumus:

dataset Dataset of stocks from Novo Cursoadsumus:

Novo Cursoadsumus is one of the companies in Brazil and 3,456,808 companies in our database.

This dashboard is based on data from: YAHOO-FIN, YFINANCE, Twitter.

This content is available under the CC BY 4.0 license.